Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Plos One|February 25, 2015
Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failureSimona Littnerova, Jiri Parenica, Jindrich Spinar, et al.
Lancet (London, England)|October 9, 2018
Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trialErin A Bohula, Benjamin M Scirica, Silvio E Inzucchi, et al.
Clinical Cardiology|May 24, 2019
Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registryMarie Pavlusova, Jiri Jarkovsky, Klara Benesova, et al.
Circulation|August 30, 2022
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63BMarc P Bonaca, David A Morrow, Brian A Bergmark, et al.
JAMA|April 5, 2016
Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical TrialMichelle L O'Donoghue, Ruchira Glaser, Matthew A Cavender, et al.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
Pageof 13